Peter G. Traber

Randomised clinical study: GR‐MD‐02, a galectin‐3 inhibitor, vs. placebo in patients having non‐alcoholic steatohepatitis with advanced fibrosis

B. Neuschwander‐Tetri, N. Chalasani, P. Traber, 2016, Alimentary pharmacology & therapeutics.

Brain edema in rabbits with galactosamine-induced fulminant hepatitis. Regional differences and effects on intracranial pressure.

D. Ganger, P. Traber, A. Blei, 1986, Gastroenterology.